December 9, 2015

Donna, PhD candidate, studies the prevention of breast cancer metastases

Hi! My name is Donna Murrell and I’m a PhD candidate in the Department of Medical Biophysics at Western University. I’m working under the supervision of Dr. Paula Foster at Robarts Research Institute, and we’re using MRI to monitor the fate of breast cancer cells in the brain. You might have seen my first blog post in March 2014.

It’s been a great month in the lab! I had a very exciting opportunity to present my research to the community at Western’s Leaders in Innovation Dinner on Nov 18. I also had my mid-level comprehensive exam, which is a major milestone for a PhD student. I’m happy (and relieved!) to say I passed!

The topic of the exam was concomitant tumour resistance, which is the concept that some primary tumours, such as breast cancer, may be able to prevent the development of metastases by inducing a state of dormancy at distant sites. Dormancy means that the cancer cell is still viable, but it doesn’t grow.

It’s really important to understand how a primary tumour could do this, because it may be possible to mimic the mechanism as a treatment strategy. I’m hoping to use our MRI cell-tracking technology to investigate this idea further in the new year.

Thank you to BCSC for your trainee support!

Donna Murrell, PhD Candidate
Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Health Sciences Centre

National Committee on Preventive Health

Breast Cancer Canada welcomes the Government of Canada’s announcement of the National Advisory Committee on Preventive Health Services and its commitment to evidence-based, transparent, and

Male Breast Cancer

June is Men’s Health Month, a time usually dedicated to conversations around heart health, prostate checks, and mental well-being. But there is another critical health

PROgress Tracker ASCO 2026

Understanding the “Burden of Worry”: New insights from PROgress Tracker Breast Cancer Registry When someone finishes active breast cancer treatment, it’s often seen as the end of

BCC’s Survivorship Strategy

What Happens After the “All Clear”? Breast Cancer Canada Calls for Urgent Action to Support Canadian Breast Cancer Survivors As more younger Canadians are being

Progress Through Research

Latest Research

Breast Cancer Canada donations fund life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis.

Patient Tools

Our suite of digital tools are each designed to help individuals better manage their breast cancer journey through education, research and personalized insights, while also elevating the patient voice.

Patient Stories

Every breast cancer journey is unique, but together, these stories paint a powerful picture of progress. Through firsthand accounts from patients and survivors, we share stories that highlight the lived-experiences of breast cancer.

Fuel Progress

Progress happens when we invest in it. Canada is home to some of the world’s brightest minds in research. Together, we are advancing science, ensuring it leads to earlier detection, better treatments, and improved outcomes for patients across the country.